Palo Alto Weekly5h
Pets in Need launches Community Veterinary Clinic to address preventative care gap
Expanding its veterinary services, Pets in Need launched its new Community Veterinary Clinic on Thursday, Nov. 14. The clinic ...
Palo Alto Networks, Inc. (PANW) Unveils Seven AI-Driven Cybersecurity Predictions for 2025
We recently compiled a list of the 10 AI News Making Waves Today. In this article, we are going to take a look at where Palo ...
The Register on MSN10h
Mystery Palo Alto Networks hijack-my-firewall zero-day now officially under exploit
Yank access to management interface, stat A critical zero-day vulnerability in Palo Alto Networks' firewall management ...
HHS13h
Palo Alto Reports Firewalls Exploited Using an Unknown Flaw
Attackers are exploiting a zero-day vulnerability in some types of Palo Alto Networks firewalls, the cybersecurity giant ...
CRN14h
Palo Alto Networks: ‘Critical’ Firewall Vulnerability Has Seen Exploitation
Palo Alto Networks disclosed that a flaw affecting some internet-exposed firewall management interfaces has seen exploitation ...
Infosecurity-magazine.com16h
Palo Alto Networks Confirms New Zero-Day Being Exploited by Threat Actors
The security provider has elevated its warning about a vulnerability affecting firewall management interfaces after observing ...
CSOonline16h
CISOs who delayed patching Palo Alto Vulnerabilities now face real threat
CISA said it has evidence of active exploitation for two out of six Expedition v Palo Alto Networks patched in October.
Palo Alto Networks price target raised to $425 from $385 at Baird
Baird raised the firm’s price target on Palo Alto Networks (PANW) to $425 from $385 and keeps an Outperform rating on the shares. The ...
Palo Alto Networks warns users of dangerous security threat affecting firewalls
Palo Alto Networks says it's aware of claims of flaws in the firewalls Company is advising users to be extra cautious and ...
Palo Alto Networks warns of potential PAN-OS RCE vulnerability
Palo Alto Networks warned customers to restrict access to their next-generation firewalls because of a potential remote code execution vulnerability in the PAN-OS management interface.
FierceBiotech24d
Alto's midphase depression trial falls flat, raising doubts about pitch to disrupt neuropsychiatry R&D
Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary ...